Riassunto
I tumori androgeno-secernenti sono neoplasie rare che causano virilizzazione nella donna. La rapida insorgenza e progressione della sintomatologia sono una peculiarità. Il sospetto clinico richiede la conferma biochimica attraverso il dosaggio di testosterone e DHEA-S e la localizzazione della neoplasia attraverso risonanza magnetica nucleare surrenalica o ecografia ovarica; qualora lo studio di imaging risulti negativo è opportuno eseguire il cateterismo venoso selettivo.
Bibliografia
Carmina E, Rosato F, Jannì A, Rizzo M, Longo RA 2006 Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 91:2–6.
Barnor Q, Kurzawinski TA, Conway S Androgen-secreting tumours. In: Hay I, Wass J eds. Clinical Endocrine Oncology. Blackwell Publishing, Ltd, 2009, 390–395.
Olt G, Mortel R 1997 Hormone-producing tumors of the ovary. Endocrine-Related Cancer 4:447–457.
Toscano V, Adamo MV, Boscherini B et al 1981 The hormone pattern in a case of arrhenoblastoma. Eur J Pediatr 136:203–206.
Allolio B, Hahner S, Weiman D, Fassnatch M 2004 Management of adrenocortical carcinoma. Clin Endocrinol (Oxf) 60:273–287.
Roman S 2006 Adrenocortical carcinoma. Curr Opin Oncol 18:36–42.
Azziz R, Carmina E, Dewailly D et al 2009 The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456–488.
Waggoner W, Boots LR, Azziz R 1999 Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study. Gynecol Endocrinol 13:394–400.
Kaltsas GA, Isidori AM, Kola BP et al 2003 The value of the low dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism. J Clin Endocrinol Metab 88:2634–2643.
Ehrmann DA, Rosenfield RL 1990 Clinical Review: an endocrinologic approach to the patient with hirsutism. J Clin Endocrinol Metab 71:1–4.
Pascale MM, Pugeat M, Roberts M et al 1994 Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours. Clin Endocrinol (Oxf) 41:571–576.
Jenebaum F, Groussin L, Foehrenbach H 2004 F-Fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenal tumours. Preliminary report of 13 consecutive patients. Eur J Endocrinol 150:789–792.
Dennedy MC, Smith D, O’Shea D, McKenna TJ 2010 Investigation of patients with atipical or severe hyperandrogenaemia including androgen-secreting ovarian teratoma. Eur J Endocrinol 162:213–220.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Motta, C., Proietti-Pannunzi, L. & Toscano, V. I tumori androgeno-secernenti nella donna: dal sospetto clinico alla diagnosi. L’Endocrinologo 14, 243–249 (2013). https://doi.org/10.1007/BF03346111
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346111